X0708 D LIVE 0001430306 Tonix Pharmaceuticals Holding Corp. 509 MADISON AVENUE SUITE 306 NEW YORK NY NEW YORK 10022 (212) 980-9155 NEVADA TAMANDARE EXPLORATIONS INC. Tamandare Explorations Inc. TAMANDARE EXPLORATIONS INC. Corporation true Seth Lederman 509 Madison Avenue Suite 306 New York NY NEW YORK 10022 Executive Officer Director Chief Executive Officer, President and Chairman Bradley Saenger 509 Madison Avenue Suite 306 New York NY NEW YORK 10022 Executive Officer Chief Financial Officer, Treasurer Gregory Sullivan 509 Madison Avenue Suite 306 New York NY NEW YORK 10022 Executive Officer Chief Medical Officer, Secretary Margaret Smith Bell 509 Madison Avenue Suite 306 New York NY NEW YORK 10022 Director Stuart Davidson 509 Madison Avenue Suite 306 New York NY NEW YORK 10022 Director Patrick Grace 509 Madison Avenue Suite 306 New York NY NEW YORK 10022 Director Donald W. Landry 509 Madison Avenue Suite 306 New York NY NEW YORK 10022 Director Ernest Mario 509 Madison Avenue Suite 306 New York NY NEW YORK 10022 Director Charles E. Mather IV 509 Madison Avenue Suite 306 New York NY NEW YORK 10022 Director John Rhodes 509 Madison Avenue Suite 306 New York NY NEW YORK 10022 Director Samuel Saks 509 Madison Avenue Suite 306 New York NY NEW YORK 10022 Director Pharmaceuticals Decline to Disclose 06b false 2017-09-28 true true false 0 15314798 314798 15000000 73,039 shares issued to Lincoln Park on 10/28/2017 as initial consideration for put right granted to the Company under the equity line agreement. Such shares are valued solely for purposes of this Form D at $4.31 (the closing stock price on 10/27/2017). false 1 0 0 0 false Tonix Pharmaceuticals Holding Corp. /s/ Bradley Saenger Bradley Saenger Chief Financial Officer 2017-10-10